HEADER HYDROLASE, LIGASE 27-OCT-05 2ETL TITLE CRYSTAL STRUCTURE OF UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 (UCH-L1) COMPND MOL_ID: 1; COMPND 2 MOLECULE: UBIQUITIN CARBOXYL-TERMINAL HYDROLASE ISOZYME L1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: UCH-L1, UBIQUITIN THIOLESTERASE L1, NEURON CYTOPLASMIC COMPND 5 PROTEIN 9.5, PGP 9.5, PGP9.5; COMPND 6 EC: 3.4.19.12, 6.-.-.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: UCHL1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-6P1 KEYWDS DEUBIQUITINATING THIOL HYDROLASE, HYDROLASE, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR C.DAS,Q.Q.HOANG,C.A.KREINBRING,S.J.LUCHANSKY,R.K.MERAY,S.S.RAY, AUTHOR 2 P.T.LANSBURY,D.RINGE,G.A.PETSKO REVDAT 4 18-OCT-17 2ETL 1 REMARK REVDAT 3 13-JUL-11 2ETL 1 VERSN REVDAT 2 24-FEB-09 2ETL 1 VERSN REVDAT 1 28-MAR-06 2ETL 0 JRNL AUTH C.DAS,Q.Q.HOANG,C.A.KREINBRING,S.J.LUCHANSKY,R.K.MERAY, JRNL AUTH 2 S.S.RAY,P.T.LANSBURY,D.RINGE,G.A.PETSKO JRNL TITL STRUCTURAL BASIS FOR CONFORMATIONAL PLASTICITY OF THE JRNL TITL 2 PARKINSON'S DISEASE-ASSOCIATED UBIQUITIN HYDROLASE UCH-L1. JRNL REF PROC.NATL.ACAD.SCI.USA V. 103 4675 2006 JRNL REFN ISSN 0027-8424 JRNL PMID 16537382 JRNL DOI 10.1073/PNAS.0510403103 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 34753 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.200 REMARK 3 FREE R VALUE TEST SET COUNT : 3369 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3482 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 4 REMARK 3 SOLVENT ATOMS : 107 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.03800 REMARK 3 B22 (A**2) : -4.03800 REMARK 3 B33 (A**2) : 8.07600 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 47.87 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : CNS_TOPPAR:PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CNS_TOPPAR:DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : CNS_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : CNS_TOPPAR:ION.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : CNS_TOPPAR:PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CNS_TOPPAR:DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : CNS_TOPPAR:WATER.TOP REMARK 3 TOPOLOGY FILE 4 : CNS_TOPPAR:ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2ETL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-NOV-05. REMARK 100 THE DEPOSITION ID IS D_1000035075. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-APR-05 REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98397 REMARK 200 MONOCHROMATOR : SI(311) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34753 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 41.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 14.10 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 14.30 REMARK 200 R MERGE FOR SHELL (I) : 0.77300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: HOMOLOGY MODEL BASED ON UCH-L3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.4 M AMMONIUM SULFATE, 0.1 M HEPES, REMARK 280 PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 4 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z REMARK 290 4555 Y+1/2,-X+1/2,Z REMARK 290 5555 -X+1/2,Y+1/2,-Z REMARK 290 6555 X+1/2,-Y+1/2,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 55.04850 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 55.04850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 55.04850 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 55.04850 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 55.04850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.04850 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 55.04850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.04850 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER, A SUBUNIT OF THE REMARK 300 ASSYMETRIC UNIT WHICH CONTAINS TWO COPIES OF THE PROTEIN MOLECULE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 11020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 34070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -106.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 220.19400 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 110.09700 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 165.14550 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 -55.04850 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 55.04850 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 165.14550 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 110.09700 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 55.04850 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 -55.04850 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 55.04850 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 55.04850 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 PRO A -3 REMARK 465 LEU A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 GLY B -4 REMARK 465 PRO B -3 REMARK 465 LEU B -2 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 43 105.30 -59.91 REMARK 500 ASN A 102 31.50 -146.28 REMARK 500 ARG A 153 -96.64 -166.02 REMARK 500 VAL A 154 132.80 61.37 REMARK 500 ASN A 159 59.25 -68.83 REMARK 500 GLN A 209 -6.93 -54.01 REMARK 500 GLN B 2 145.03 -173.31 REMARK 500 ALA B 23 -126.49 13.74 REMARK 500 GLU B 35 -129.30 -77.66 REMARK 500 PHE B 62 -52.72 77.19 REMARK 500 ASN B 102 34.17 -144.08 REMARK 500 PHE B 108 124.26 68.22 REMARK 500 GLU B 109 -179.94 -59.76 REMARK 500 ASP B 110 -85.39 -52.53 REMARK 500 LYS B 123 45.51 36.79 REMARK 500 ASP B 155 166.31 -14.43 REMARK 500 ASP B 156 -103.98 -69.51 REMARK 500 HIS B 185 42.30 -97.36 REMARK 500 THR B 192 24.28 -73.63 REMARK 500 ARG B 207 24.31 -62.75 REMARK 500 ALA B 222 85.86 58.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 3001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 3002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 3003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 3004 DBREF 2ETL A 1 223 UNP P09936 UCHL1_HUMAN 1 223 DBREF 2ETL B 1 223 UNP P09936 UCHL1_HUMAN 1 223 SEQADV 2ETL GLY A -4 UNP P09936 CLONING ARTIFACT SEQADV 2ETL PRO A -3 UNP P09936 CLONING ARTIFACT SEQADV 2ETL LEU A -2 UNP P09936 CLONING ARTIFACT SEQADV 2ETL GLY A -1 UNP P09936 CLONING ARTIFACT SEQADV 2ETL SER A 0 UNP P09936 CLONING ARTIFACT SEQADV 2ETL GLY B -4 UNP P09936 CLONING ARTIFACT SEQADV 2ETL PRO B -3 UNP P09936 CLONING ARTIFACT SEQADV 2ETL LEU B -2 UNP P09936 CLONING ARTIFACT SEQADV 2ETL GLY B -1 UNP P09936 CLONING ARTIFACT SEQADV 2ETL SER B 0 UNP P09936 CLONING ARTIFACT SEQRES 1 A 228 GLY PRO LEU GLY SER MET GLN LEU LYS PRO MET GLU ILE SEQRES 2 A 228 ASN PRO GLU MET LEU ASN LYS VAL LEU SER ARG LEU GLY SEQRES 3 A 228 VAL ALA GLY GLN TRP ARG PHE VAL ASP VAL LEU GLY LEU SEQRES 4 A 228 GLU GLU GLU SER LEU GLY SER VAL PRO ALA PRO ALA CYS SEQRES 5 A 228 ALA LEU LEU LEU LEU PHE PRO LEU THR ALA GLN HIS GLU SEQRES 6 A 228 ASN PHE ARG LYS LYS GLN ILE GLU GLU LEU LYS GLY GLN SEQRES 7 A 228 GLU VAL SER PRO LYS VAL TYR PHE MET LYS GLN THR ILE SEQRES 8 A 228 GLY ASN SER CYS GLY THR ILE GLY LEU ILE HIS ALA VAL SEQRES 9 A 228 ALA ASN ASN GLN ASP LYS LEU GLY PHE GLU ASP GLY SER SEQRES 10 A 228 VAL LEU LYS GLN PHE LEU SER GLU THR GLU LYS MET SER SEQRES 11 A 228 PRO GLU ASP ARG ALA LYS CYS PHE GLU LYS ASN GLU ALA SEQRES 12 A 228 ILE GLN ALA ALA HIS ASP ALA VAL ALA GLN GLU GLY GLN SEQRES 13 A 228 CYS ARG VAL ASP ASP LYS VAL ASN PHE HIS PHE ILE LEU SEQRES 14 A 228 PHE ASN ASN VAL ASP GLY HIS LEU TYR GLU LEU ASP GLY SEQRES 15 A 228 ARG MET PRO PHE PRO VAL ASN HIS GLY ALA SER SER GLU SEQRES 16 A 228 ASP THR LEU LEU LYS ASP ALA ALA LYS VAL CYS ARG GLU SEQRES 17 A 228 PHE THR GLU ARG GLU GLN GLY GLU VAL ARG PHE SER ALA SEQRES 18 A 228 VAL ALA LEU CYS LYS ALA ALA SEQRES 1 B 228 GLY PRO LEU GLY SER MET GLN LEU LYS PRO MET GLU ILE SEQRES 2 B 228 ASN PRO GLU MET LEU ASN LYS VAL LEU SER ARG LEU GLY SEQRES 3 B 228 VAL ALA GLY GLN TRP ARG PHE VAL ASP VAL LEU GLY LEU SEQRES 4 B 228 GLU GLU GLU SER LEU GLY SER VAL PRO ALA PRO ALA CYS SEQRES 5 B 228 ALA LEU LEU LEU LEU PHE PRO LEU THR ALA GLN HIS GLU SEQRES 6 B 228 ASN PHE ARG LYS LYS GLN ILE GLU GLU LEU LYS GLY GLN SEQRES 7 B 228 GLU VAL SER PRO LYS VAL TYR PHE MET LYS GLN THR ILE SEQRES 8 B 228 GLY ASN SER CYS GLY THR ILE GLY LEU ILE HIS ALA VAL SEQRES 9 B 228 ALA ASN ASN GLN ASP LYS LEU GLY PHE GLU ASP GLY SER SEQRES 10 B 228 VAL LEU LYS GLN PHE LEU SER GLU THR GLU LYS MET SER SEQRES 11 B 228 PRO GLU ASP ARG ALA LYS CYS PHE GLU LYS ASN GLU ALA SEQRES 12 B 228 ILE GLN ALA ALA HIS ASP ALA VAL ALA GLN GLU GLY GLN SEQRES 13 B 228 CYS ARG VAL ASP ASP LYS VAL ASN PHE HIS PHE ILE LEU SEQRES 14 B 228 PHE ASN ASN VAL ASP GLY HIS LEU TYR GLU LEU ASP GLY SEQRES 15 B 228 ARG MET PRO PHE PRO VAL ASN HIS GLY ALA SER SER GLU SEQRES 16 B 228 ASP THR LEU LEU LYS ASP ALA ALA LYS VAL CYS ARG GLU SEQRES 17 B 228 PHE THR GLU ARG GLU GLN GLY GLU VAL ARG PHE SER ALA SEQRES 18 B 228 VAL ALA LEU CYS LYS ALA ALA HET CL A3003 1 HET CL A3004 1 HET CL B3001 1 HET CL B3002 1 HETNAM CL CHLORIDE ION FORMUL 3 CL 4(CL 1-) FORMUL 7 HOH *107(H2 O) HELIX 1 1 ASN A 9 LEU A 20 1 12 HELIX 2 2 THR A 56 LYS A 71 1 16 HELIX 3 3 SER A 89 ASN A 101 1 13 HELIX 4 4 SER A 112 THR A 121 1 10 HELIX 5 5 SER A 125 ASN A 136 1 12 HELIX 6 6 ASN A 136 GLN A 148 1 13 HELIX 7 7 THR A 192 ARG A 207 1 16 HELIX 8 8 ASN B 9 LEU B 20 1 12 HELIX 9 9 THR B 56 GLU B 69 1 14 HELIX 10 10 SER B 89 ASN B 101 1 13 HELIX 11 11 SER B 112 GLU B 122 1 11 HELIX 12 12 SER B 125 GLU B 134 1 10 HELIX 13 13 ASN B 136 GLN B 148 1 13 HELIX 14 14 THR B 192 ARG B 207 1 16 SHEET 1 A 6 TRP A 26 ASP A 30 0 SHEET 2 A 6 SER A 215 LYS A 221 -1 O ALA A 218 N VAL A 29 SHEET 3 A 6 ALA A 46 PRO A 54 -1 N LEU A 52 O SER A 215 SHEET 4 A 6 PHE A 160 VAL A 168 -1 O ILE A 163 N LEU A 51 SHEET 5 A 6 HIS A 171 LEU A 175 -1 O TYR A 173 N ASN A 166 SHEET 6 A 6 VAL A 183 ALA A 187 -1 O GLY A 186 N LEU A 172 SHEET 1 B 6 ARG B 27 VAL B 31 0 SHEET 2 B 6 SER B 215 CYS B 220 -1 O ALA B 218 N VAL B 29 SHEET 3 B 6 ALA B 46 PRO B 54 -1 N LEU B 52 O SER B 215 SHEET 4 B 6 PHE B 160 ASN B 167 -1 O ILE B 163 N LEU B 51 SHEET 5 B 6 HIS B 171 LEU B 175 -1 O TYR B 173 N ASN B 166 SHEET 6 B 6 VAL B 183 ALA B 187 -1 O HIS B 185 N LEU B 172 CISPEP 1 ALA A 44 PRO A 45 0 -0.10 SITE 1 AC1 2 GLN B 84 ASN B 88 SITE 1 AC2 1 ASP B 169 SITE 1 AC3 2 GLN A 84 ASN A 88 SITE 1 AC4 1 ASP A 169 CRYST1 110.097 110.097 79.489 90.00 90.00 90.00 P 4 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009083 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009083 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012580 0.00000 MASTER 350 0 4 14 12 0 4 6 0 0 0 36 END